MedAI Verdict
All comparisons

Octagos vs Regard

Cardiology clinics with implanted device patients are the Octagos buyers. Octagos describes a two-step workflow, with Atlas AI analyzing each transmission first and an IBHRE-certified specialist finalizing, and a physician e-signature required on every report. Hospital clinical documentation and finance staff are the Regard buyers, wanting chart-wide diagnosis recommendations, each with an evidence chain according to the vendor.

Octagos reports 1 billion+ transmission pages processed and a 21-day average to EHR go-live. Regard reports 12,993,284 recommended diagnoses accepted by clinicians and shows Banner Health, Eisenhower Health and WakeMed on its homepage. All of these are vendor figures.

The openFDA 510(k) file holds nothing under Octagos, Octagos Health or Regard as applicant. Regard states audit logging on every assessment and data fetch, and Octagos states SOC 2 Type 2 and SOC 3 on Microsoft Azure. A hospital that runs both a device clinic and a documentation program would sign two contracts with two owners.

Decision support · Reviewed November 2, 2026

Octagos logo

Octagos

by Octagos

Remote cardiac device monitoring where AI triages implantable device transmissions and US specialists review them, for cardiology clinics.

Regard logo

Regard

by Regard

AI platform that reviews the full EHR chart, suggests supported diagnoses with evidence, and drafts clinical notes for physician approval.

When to pick each one

Octagos

  • IBHRE-certified specialist review of device transmissions
  • Abbott, Medtronic, Boston Scientific devices, vendor-neutral claim
  • 21 days average to EHR go-live, vendor says
Read the full Octagos review

Regard

  • Diagnosis recommendations, vendor says each has evidence chain
  • Banner Health and WakeMed shown as customers
Read the full Regard review

Score

Each row shows points earned of points available under the published rubric.

Octagos

43of 100

Competitive

Regard

9of 100

Tracked
Score by dimension for Octagos and Regard
DimensionOctagosRegardDifference
FDA clearance0 / 120 / 120
HIPAA / SOC2 / BAA10 / 100 / 10+10
EHR integrations (count)2.8 / 5.61.7 / 5.6+1.1
Top-3 EHR coverage (Epic / Oracle / Athena)4.8 / 4.81.9 / 4.8+2.9
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers14.7 / 210 / 21+14.7
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal3 / 123 / 120
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Octagos

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Regard

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

Regard

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Compliance and integrations

Documented from each vendor’s own pages.

SpecOctagosRegard
Free tierNo / unverifiedNo / unverified
HIPAAYesNo / unverified
SOC 2 Type IIYesNo / unverified
EHR integrationsEpic, Oracle Health, athenahealth, medent, NextGenEpic
Foundedn/an/a
HQUSn/a

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.